ROS-dependent S-palmitoylation activates cleaved and intact gasdermin D
Gasdermin D (GSDMD) is the common effector for cytokine secretion and pyroptosis downstream of inflammasome activation and was previously shown to form large transmembrane pores after cleavage by inflammatory caspases to generate the GSDMD N-terminal domain (GSDMD-NT) 1 – 10 . Here we report that GS...
Saved in:
Published in | Nature (London) Vol. 630; no. 8016; pp. 437 - 446 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
13.06.2024
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Gasdermin D (GSDMD) is the common effector for cytokine secretion and pyroptosis downstream of inflammasome activation and was previously shown to form large transmembrane pores after cleavage by inflammatory caspases to generate the GSDMD N-terminal domain (GSDMD-NT)
1
–
10
. Here we report that GSDMD Cys191 is
S
-palmitoylated and that palmitoylation is required for pore formation.
S
-palmitoylation, which does not affect GSDMD cleavage, is augmented by mitochondria-generated reactive oxygen species (ROS). Cleavage-deficient GSDMD (D275A) is also palmitoylated after inflammasome stimulation or treatment with ROS activators and causes pyroptosis, although less efficiently than palmitoylated GSDMD-NT. Palmitoylated, but not unpalmitoylated, full-length GSDMD induces liposome leakage and forms a pore similar in structure to GSDMD-NT pores shown by cryogenic electron microscopy. ZDHHC5 and ZDHHC9 are the major palmitoyltransferases that mediate GSDMD palmitoylation, and their expression is upregulated by inflammasome activation and ROS. The other human gasdermins are also palmitoylated at their N termini. These data challenge the concept that cleavage is the only trigger for GSDMD activation. They suggest that reversible palmitoylation is a checkpoint for pore formation by both GSDMD-NT and intact GSDMD that functions as a general switch for the activation of this pore-forming family.
Gasdermin D Cys191 is
S
-palmitoylated, and palmitoylation is required for pore formation. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally: Gang Du, Liam B. Healy. Author contributions H.W., G.D., L.B.H., L.D., C.W. and J.L. conceived the study. G.D. designed and performed most of the experiments. L.B.H. designed and performed most of the remaining experiments. T.J.E.-B. and C.A.L. designed and performed intact MS under C.V.R.’s supervision. B. Goh and G.D. designed and performed UPLC–MS/MS analysis with S.F.O. and H.W.’s supervision. B. Gu performed CRISPR–Cas9 knockout of ZDHHC5 and ZDHHC9 under J.L.’s supervision. P.D. prepared primary BMDMs under J.C.K.’s supervision. A. Balasubramanian and H.R.L. provided siRNAs for knocking down ZDHHC genes. X.P. helped with cryo-EM data processing for full-length GSDMD pore structure. P.F. and Y.D. helped with GSDMD and CASP1 expression, respectively. R.M. provided Crls1- or Plscr3-KO iBMDMs. X.M. attempted knock-in of the Halo tag to GSDMD in THP-1 cells. R.P. and A. Banerjee provided Heatil screen constructs. H.W., L.B.H., G.D. and J.L. wrote the manuscript with input from all of the authors. |
ISSN: | 0028-0836 1476-4687 1476-4687 |
DOI: | 10.1038/s41586-024-07373-5 |